Insider Stock Trading History of Lindop Christopher J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lindop Christopher J since year 2005. The trader's CIK number is 1266051. At the time of this reporting, Lindop Christopher J is the Director of Parexel International Corp . (stock ticker symbol PRXL). See this page for all insider trading activities at Parexel International Corp .

Note that in the past LINDOP CHRISTOPHER J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lindop Christopher J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-03-01 PRXL Parexel International Corp Sale 2,000 60.28 120,560
2015-10-26 HAE Haemonetics Corp Sale 436 32.13 14,008
2015-08-20 HAE Haemonetics Corp Sale 4,902 38.49 188,687
2015-08-20 HAE Haemonetics Corp Option Ex 4,902 26.32 128,996
2015-07-20 HAE Haemonetics Corp Option Ex 4,902 26.32 128,996
2015-07-20 HAE Haemonetics Corp Sale 4,902 39.09 191,609
2015-06-22 HAE Haemonetics Corp Sale 4,902 42.51 208,393
2015-06-22 HAE Haemonetics Corp Option Ex 4,902 26.32 128,996
2015-05-20 HAE Haemonetics Corp Option Ex 4,902 26.32 128,996
2015-05-20 HAE Haemonetics Corp Sale 4,902 41.65 204,173
2015-04-20 HAE Haemonetics Corp Sale 4,902 41.55 203,678
2015-04-20 HAE Haemonetics Corp Option Ex 4,902 26.32 128,996
2015-03-20 HAE Haemonetics Corp Option Ex 4,902 26.32 128,996
2015-03-20 HAE Haemonetics Corp Sale 4,902 44.26 216,982
2015-02-19 PRXL Parexel International Corp Sale 2,000 63.59 127,180
2014-11-05 PRXL Parexel International Corp Sale 12,000 55.00 660,000
2014-02-04 PRXL Parexel International Corp Sale 10,000 49.00 490,000
2013-06-18 HAE Haemonetics Corp Option Ex 68,628 26.32 1,805,945
2013-06-18 HAE Haemonetics Corp Sale 68,628 42.50 2,916,690
2013-05-21 HAE Haemonetics Corp Option Ex 42,882 27.28 1,169,606
2013-05-21 HAE Haemonetics Corp Sale 42,882 42.00 1,801,044
2013-04-30 HAE Haemonetics Corp Buy 412 32.72 13,482
2013-02-12 PRXL Parexel International Corp Sale 2,543 34.40 87,479
2012-11-20 HAE Haemonetics Corp Sale 278 80.95 22,504
2012-11-01 HAE Haemonetics Corp Buy 132 61.46 8,112
2012-09-25 PRXL Parexel International Corp Sale 5,112 30.92 158,063
2012-09-11 PRXL Parexel International Corp Sale 7,800 30.10 234,780
2012-09-04 HAE Haemonetics Corp Option Ex 61,783 49.58 3,063,201
2012-09-04 HAE Haemonetics Corp Sale 61,783 74.50 4,602,833
2012-05-01 HAE Haemonetics Corp Buy 264 49.83 13,154
2012-03-08 PRXL Parexel International Corp Sale 4,000 24.33 97,320
2011-11-03 HAE Haemonetics Corp Buy 217 51.81 11,242
2011-09-19 PRXL Parexel International Corp Sale 2,500 20.98 52,450
2011-09-13 PRXL Parexel International Corp Sale 2,200 20.34 44,748
2011-05-04 HAE Haemonetics Corp Buy 273 46.80 12,776
2010-12-10 HAE Haemonetics Corp Option Ex 8,782 48.09 422,326
2010-12-10 HAE Haemonetics Corp Sale 8,782 62.71 550,736
2010-12-13 HAE Haemonetics Corp Option Ex 9,050 48.09 435,214
2010-12-13 HAE Haemonetics Corp Sale 9,050 62.26 563,480
2010-11-04 HAE Haemonetics Corp Buy 297 46.34 13,761
2010-04-30 HAE Haemonetics Corp Buy 279 45.70 12,751
2010-02-08 PRXL Parexel International Corp Sale 1,000 19.18 19,175
2009-12-02 PRXL Parexel International Corp Sale 2,000 12.60 25,200
2009-10-30 HAE Haemonetics Corp Buy 166 44.13 7,325
2009-10-26 HAE Haemonetics Corp Sale 107 54.52 5,833
2009-05-01 HAE Haemonetics Corp Buy 277 43.89 12,156
2008-10-31 HAE Haemonetics Corp Buy 213 45.44 9,678
2008-10-30 PRXL Parexel International Corp Buy 2,000 10.32 20,650
2008-10-27 HAE Haemonetics Corp Sale 107 50.08 5,358
2008-05-01 HAE Haemonetics Corp Buy 260 44.35 11,531
2007-11-01 HAE Haemonetics Corp Buy 284 40.66 11,548
2006-11-01 PRXL Parexel International Corp Buy 1,000 30.05 30,050

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lindop Christopher J (Director of Parexel International Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.